| Powering MEMS portable devices—a review of non-regenerative and regenerative power supply systems with special emphasis on piezoelectric energy harvesting systems KA Cook-Chennault, N Thambi, AM Sastry Smart materials and structures 17 (4), 043001, 2008 | 1588 | 2008 |
| Bispecific antibodies and antibody–drug conjugates (ADCs) bridging HER2 and prolactin receptor improve efficacy of HER2 ADCs J Andreev, N Thambi, AE Perez Bay, F Delfino, J Martin, MP Kelly, ... Molecular cancer therapeutics 16 (4), 681-693, 2017 | 137 | 2017 |
| Piezoelectric energy harvesting: a green and clean alternative for sustained power production KA Cook-Chennault, N Thambi, MA Bitetto, EB Hameyie Bulletin of Science, Technology & Society 28 (6), 496-509, 2008 | 110 | 2008 |
| Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates MA Monslow, S Elbashir, NL Sullivan, DS Thiriot, P Ahl, J Smith, E Miller, ... Vaccine 38 (36), 5793-5802, 2020 | 71 | 2020 |
| Dll4 blockade in stromal cells mediates antitumor effects in preclinical models of ovarian cancer F Kuhnert, G Chen, S Coetzee, N Thambi, C Hickey, J Shan, P Kovalenko, ... Cancer research 75 (19), 4086-4096, 2015 | 45 | 2015 |
| Multispecific antigen-binding molecules and uses thereof J Andreev, N Thambi, F Delfino, J Martin, G Thurston, K Cygnar, ... US Patent 11,129,903, 2021 | 8 | 2021 |
| Single cell multi-omic reference atlases of non-human primate immune tissues reveals CD102 as a biomarker for long-lived plasma cells RP Staupe, KE Lodge, N Thambi, D Toole, AM Tamburino, D Chang, ... Communications Biology 5 (1), 1399, 2022 | 5 | 2022 |
| Piezoelectric Energy Harvesting: A Green and Clean Alternative for Sustained Power Production EB Hameyie, MA Bitetto, N Thambi, KA Cook-Chennault | 4 | 2008 |
| Targeting shared hotspot cancer mutations with a Listeria monocytogenes immunotherapy induce potent anti-tumor immunity D Villarreal, B Coder, S Armington, A L’Huillier, C Mattershead, ... Proceedings of the AACR Annual Meeting, 2018 | 3 | 2018 |
| Evaluation of Angiogenesis Inhibitors Using the HUVEC Fibrin Bead Sprouting Assay L Winters, N Thambi, J Andreev, F Kuhnert Bio-protocol 6 (19), e1947-e1947, 2016 | 2 | 2016 |
| Listeria monocytogenes personalized cancer vaccines drive therapeutic immune responses to cancer derived neoantigens B Coder, O Pryshchep, D Kelkar, E Filippova, X Ju, D Balli, C Mottershead, ... bioRxiv, 2020.05. 11.088930, 2020 | 1 | 2020 |
| Elucidating the Immunogenic Mechanisms of Merck’s Lipid Nanoparticle (LNP) Adjuvants NL Sullivan, S Secore, A Bass, M Wolf, A Dangizer, N Thambi, ... The Journal of Immunology 210 (1_Supplement), 159.18-159.18, 2023 | | 2023 |
| Multispecific antigen-binding molecules and uses thereof G Thurston, J Andreev, N Thambi, F Delfino, J Martin, K Cygnar, ... | | 2023 |
| Multispecific antigen-binding molecules and uses thereof J Andreev, N Thambi, F Delfino, J Martin, G Thurston, K Cygnar, ... US Patent App. 17/483,588, 2022 | | 2022 |
| Multispecific antigen-binding molecules and uses thereof J Andreev, N Thambi, F Delfino, J Martin, G Thurston, K Cygnar, ... US Patent 11,191,844, 2021 | | 2021 |
| Abstract LB-149: Targeting shared hotspot cancer mutations with a Listeria monocytogenes immunotherapy induce potent anti-tumor immunity D Villarreal, B Coder, S Armington, A L'Huillier, C Mottershead, ... Cancer Research 78 (13_Supplement), LB-149-LB-149, 2018 | | 2018 |
| Listeria monocytogenes-based immunotherapies alter the suppressive phenotype of intratumoral regulatory T cells RE Kosoff, N Thambi, LK Pettit, DO Villarreal, K Ramos, MF Princiotta, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 5, 2017 | | 2017 |
| Fast constitutive turnover of the potential ADC target Prolactin Receptor (PRLR) is mediated by a 21-amino acid region in its cytoplasmic domain. J Andreev, N Thambi, AP Bay, G Thurston MOLECULAR BIOLOGY OF THE CELL 28, 2017 | | 2017 |
| Arrayed CRISPR-based imaging screen reveals that the coatomer subunit alpha (COPA) regulates surface expression of the ADC target prolactin receptor (PRLR). AE Bay, A Kalsy, N Thambi, T Young, E Pasnikowski, J Andreev, C Daly MOLECULAR BIOLOGY OF THE CELL 28, 2017 | | 2017 |
| Abstract A131: Rapid constitutive internalization and degradation of prolactin receptor (PRLR) is associated with potent cell killing by PRLR antibody drug conjugates (ADC) J Andreev, NI Thambi, F Delfino, J Martin, MP Kelly, JR Kirshner, ... Molecular Cancer Therapeutics 14 (12_Supplement_2), A131-A131, 2015 | | 2015 |
